Condition
Ultraviolet Rays
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03526068Not ApplicableCompletedPrimary
Proof-of-concept Study on Disinfection and Healing Acceleration Capabilities of 222nm Wave Length Narrow Band Ultraviolet Lighting Device
NCT01978483Phase 1CompletedPrimary
Effect of RANKL Inhibition on UV-induced Immunosuppression
NCT00705887Not ApplicableCompletedPrimary
A Motivational Enhancement Approach to Skin Cancer Prevention
NCT00685438Completed
Ultraviolet Exposure, Antioxidant Use and Skin Erythema at Extreme High Altitude
Showing all 4 trials